1 results match your criteria: "Research Institute of Infectious and Parasitic Disease[Affiliation]"
BCG vaccine therapy for treatment of superficial bladder cancer.
Int Urol Nephrol
December 1989
Department of Immunology, Research Institute of Infectious and Parasitic Disease, Sofia, Bulgaria.
A total of 42 patients were involved in the study of the effectiveness of BCG vaccine on superficial bladder tumours. The new Bulgarian vaccine CALGEVAX was administered intravesically in consecutive instillations once weekly and then once monthly for a period of 11 months. For intradermal application the F-70 subcellular preparation was used.
View Article and Find Full Text PDF